Annual Total Liabilities
$24.10 M
-$9.42 M-28.10%
December 31, 2023
Summary
- As of February 8, 2025, XLO annual total liabilities is $24.10 million, with the most recent change of -$9.42 million (-28.10%) on December 31, 2023.
- During the last 3 years, XLO annual total liabilities has fallen by -$95.50 million (-79.85%).
- XLO annual total liabilities is now -79.85% below its all-time high of $119.60 million, reached on December 31, 2020.
Performance
XLO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$53.68 M
-$2.77 M-4.91%
September 30, 2024
Summary
- As of February 8, 2025, XLO quarterly total liabilities is $53.68 million, with the most recent change of -$2.77 million (-4.91%) on September 30, 2024.
- Over the past year, XLO quarterly total liabilities has increased by +$29.59 million (+122.76%).
- XLO quarterly total liabilities is now -79.46% below its all-time high of $261.33 million, reached on June 30, 2021.
Performance
XLO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
XLO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.1% | +122.8% |
| 3 y3 years | -79.8% | +122.8% |
| 5 y5 years | +1695.3% | +122.8% |
XLO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -28.1% | at low | -5.6% | +122.8% |
| 5 y | 5-year | -79.8% | at low | -79.5% | +122.8% |
| alltime | all time | -79.8% | +5631.0% | -79.5% | +122.8% |
Xilio Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $53.68 M(-4.9%) |
| Jun 2024 | - | $56.46 M(-0.7%) |
| Mar 2024 | - | $56.84 M(+135.9%) |
| Dec 2023 | $24.10 M(-28.1%) | $24.10 M(-4.9%) |
| Sep 2023 | - | $25.34 M(+1.4%) |
| Jun 2023 | - | $24.98 M(-6.5%) |
| Mar 2023 | - | $26.71 M(-20.3%) |
| Dec 2022 | $33.52 M | $33.52 M(+7.7%) |
| Sep 2022 | - | $31.12 M(-8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $33.91 M(+12.2%) |
| Mar 2022 | - | $30.23 M(-7.4%) |
| Dec 2021 | $32.63 M(-72.7%) | $32.63 M(-87.3%) |
| Sep 2021 | - | $257.18 M(-1.6%) |
| Jun 2021 | - | $261.33 M(+118.5%) |
| Dec 2020 | $119.60 M(+29.7%) | $119.60 M |
| Dec 2019 | $92.25 M(+6772.2%) | - |
| Dec 2018 | $1.34 M(+219.2%) | - |
| Dec 2017 | $420.50 K(-13.4%) | - |
| Dec 2016 | $485.70 K | - |
FAQ
- What is Xilio Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Xilio Therapeutics?
- What is Xilio Therapeutics annual total liabilities year-on-year change?
- What is Xilio Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly total liabilities year-on-year change?
What is Xilio Therapeutics annual total liabilities?
The current annual total liabilities of XLO is $24.10 M
What is the all time high annual total liabilities for Xilio Therapeutics?
Xilio Therapeutics all-time high annual total liabilities is $119.60 M
What is Xilio Therapeutics annual total liabilities year-on-year change?
Over the past year, XLO annual total liabilities has changed by -$9.42 M (-28.10%)
What is Xilio Therapeutics quarterly total liabilities?
The current quarterly total liabilities of XLO is $53.68 M
What is the all time high quarterly total liabilities for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly total liabilities is $261.33 M
What is Xilio Therapeutics quarterly total liabilities year-on-year change?
Over the past year, XLO quarterly total liabilities has changed by +$29.59 M (+122.76%)